Lv3
240 积分 2021-12-28 加入
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
11小时前
已完结
Breast Cancer Treatment
13天前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
1个月前
已完结
Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
10个月前
已完结
Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group
10个月前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
10个月前
已完结
TOXICAN: a guide for grading dermatological adverse events of cancer treatments
1年前
已完结
Can hydrogen anion be a possible intermediate of the hydrogen electrode reaction
1年前
已完结
Metal surfaces catalyse polarization-dependent hydride transfer from H2
1年前
已完结
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
1年前
已完结
皖公网安备34019202002308
